Moderna

Latest Stories

FILE - A health worker administers a dose of COVID-19 vaccine during a vaccination clinic in Reading, Pa. COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus — even though it’s not clear if any change is needed. (AP Photo/Matt Rourke, File)

COVID shots still work but researchers hunt new improvements

By Lauran Neergaard - Associated Press

A member of the Philadelphia Fire Department prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia, on March 26, 2021. A government advisory panel is meeting Thursday, Dec. 16, to determine if any restrictions are needed to the Johnson &amp; Johnson COVID-19 vaccine because of rare but serious blood clots. (AP Photo/Matt Rourke, File)

Johnson & Johnson suspends sales forecasts for its COVID-19 vaccine

By Tom Murphy - Associated Press

In this file photo, Senate Majority Leader Chuck Schumer, D-N.Y., meets with reporters following a Democratic Caucus meeting, at the Capitol in Washington, Tuesday, April 5, 2022. Mr. Schumer accused Republicans Wednesday of using the issue of border security to gain an upper hand in blocking passage of a COVID-19 relief package. (AP Photo/J. Scott Applewhite) **FILE**

Senate virus deal in limbo as GOP pushes for border-measure vote

By Tom Howell Jr. - The Washington Times

FILE - Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

Who really needs a second COVID booster? Here’s what to know

By Lauran Neergaard - Associated Press

Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

FDA authorizes a second COVID-19 booster for adults over 50

By Tom Howell Jr. - The Washington Times

A vial filled with the Moderna COVID-19 vaccine rests by syringes waiting to be loaded by nurses from the Jackson-Hinds Comprehensive Health Center, at a vaccination station next to Jackson State University in Jackson, Miss., Tuesday, Dec. 7, 2021. (AP Photo/Rogelio V. Solis, File)

Moderna to seek FDA authorization of COVID-19 vaccine for children ages 6 months to 6 years

By Tom Howell Jr. - The Washington Times

In this file photo, Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, testifies at a Senate committee hearing on Tuesday, Jan. 11, 2022, on Capitol Hill in Washington. On March 23, 2022, Dr. Walensky said her agency is tracking the BA.2 omicron subvariant that caused spikes overseas but the strain, but that it does not appear to make infected persons any sicker and is not straining hospital capacity. (Shawn Thew/Pool via AP) ** FILE **

CDC says BA.2 variant is slowly taking over but not making people sicker

By Tom Howell Jr. - The Washington Times

A syringe is prepared with the Pfizer COVID-19 vaccine at a vaccination clinic at the Keystone First Wellness Center in Chester, Pa., on Dec. 15, 2021. Pfizer is expected to request authorization for an additional COVID-19 booster dose for seniors. (AP Photo/Matt Rourke, File) **FILE**

American taxpayers are being bilked for billions of COVID-19 dollars

By Cheryl K. Chumley - The Washington Times

In this March 4, 2021 file photo, a vial of the Moderna COVID-19 vaccine rests on a table at a drive-up mass vaccination site in Puyallup, Wash., south of Seattle. Moderna’s COVID-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year. (AP Photo/Ted S. Warren, File)

Moderna seeks FDA authorization for 4th dose of COVID shot for all adults

By Zeke Miller - Associated Press

Kidney transplant patient Sophia Silvaamaya, 5, held by her father Pedro Silvaamaya, is vaccinated by nurse Kelly Vanderwende, Wednesday, Nov. 3, 2021, at Children's National Hospital in Washington. (AP Photo/Carolyn Kaster) ** FILE **

Scientists scramble on COVID-19 vaccine dosing; challenge remains for drugmakers

By Tom Howell Jr. - The Washington Times

Masks have been required in public, even for those who keep up with COVID-19 vaccinations. Effective prevention and treatment methods have eluded experts, who lose public trust with every policy reversal and failure to control the pandemic. (Associated Press)

COVID-19 vaccines’ flaws dash hopes of reaching herd immunity

By Tom Howell Jr. - The Washington Times

Protesters opposing vaccine mandates gather at the Capitol in Sacramento, Calif., Wednesday, Sept. 8, 2021. State Sen. Scott Wiener, D-San Francisco, is introducing, Friday, Jan. 21, 2022, a bill that would allow children age 12 and up to be vaccinated without their parents' consent. (AP Photo/Rich Pedroncelli, File)

Scientists struggle to break COVID-19 vaccine skepticism, dash outlandish claims

By Kery Murakami - The Washington Times

A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore., Monday, Dec. 27, 2021. U.S. regulators have granted full approval to Moderna’s COVID-19 vaccine after reviewing additional data on its safety and effectiveness. The decision Monday, Jan. 31, 2022, by the Food and Drug Administration comes after many tens of millions of Americans have already received the shot under its original emergency authorization. Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines. (AP Photo/Jenny Kane)

Moderna announces full U.S. approval for its COVID-19 vaccine

By Matthew Perrone - Associated Press

Pharmacist Kenni Clark prepares a booster dose of the Moderna COVID-19 vaccine during a vaccination clinic at City of Lawrence's The Center, which serves seniors, families and the community, on Wednesday, Dec. 29, 2021, in Lawrence, Mass. U.S. regulators, on Friday, Jan. 7, 2022, are shortening the time that people who received Moderna's COVID-19 vaccine have to wait for a booster — to five months rather than six. The Moderna vaccine is open to Americans 18 and older. (AP Photo/Charles Krupa) **FILE**

FDA shrinks time for Moderna’s COVID-19 vaccine booster to five months

By Shen Wu Tan - The Washington Times

Nurse Sheena Davis administers a dose of a Moderna COVID-19 vaccine during a vaccination clinic at the Keystone First Wellness Center in Chester, Pa., Wednesday, Dec. 15, 2021. (AP Photo/Matt Rourke)

Moderna says COVID-19 booster offers ‘reassuring’ protection against omicron

By Tom Howell Jr. - The Washington Times

People wait in a long line to get tested for COVID-19 in Times Square, New York, Monday, Dec. 20, 2021. Just a couple of weeks ago, New York City seemed like a relative bright spot in the U.S. coronavirus struggle. Now it's a hot spot, confronting a dizzying spike in cases, a scramble for testing, a quandary over a major event and an exhausting sense of déjà vu. (AP Photo/Seth Wenig)

Omicron spooks Wall Street, infects VIPs and spurs new rules

By Tom Howell Jr. - The Washington Times

In this Oct. 8, 2013, photo, a sign marks the entrance to the federal Centers for Disease Control and Prevention (CDC) in Atlanta. (AP Photo/David Goldman) **FILE**

CDC panel recommends Pfizer, Moderna shots over J&J vaccine, citing rare blood-clotting side effect

By Tom Howell Jr. - The Washington Times

Nurse Mary Ezzat prepares to administer a Pfizer COVID-19 booster shot. (Jeff Gritchen/The Orange County Register via AP)

Lab teams race to test vaccines’ strength against omicron variant

By Tom Howell Jr. - The Washington Times

Pedestrians pass the New York Stock Exchange, Tuesday, Nov. 30, 2021, in New York. (AP Photo/John Minchillo)

Omicron variant spooks Wall Street; Dow takes a tumble

By Tom Howell Jr. - The Washington Times

FILE - A patient waits to be called for a COVID-19 vaccination booster shot outside a pharmacy in a grocery store, on Nov. 3, 2021, in downtown Denver. U.S. regulators have opened up COVID-19 booster shots to all and more adults, Friday, Nov. 19, letting them choose another dose of either the Pfizer or Moderna vaccine. (AP Photo/David Zalubowski, File)

Maryland expands booster shot eligibility to all adults

Associated Press